INVIVYD, INC. Shares Outstanding (Cover Page)
INVIVYD, INC. (IVVD) had Shares Outstanding (Cover Page) of 294.76 million shares as of 2026-07-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-07-30: Entity Common Stock, Shares Outstanding 294.76M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 294.61M shares.
- 2026-02-26: Entity Common Stock, Shares Outstanding 282.59M shares.
- 2025-10-30: Entity Common Stock, Shares Outstanding 233.12M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 294.76M shares 10-Q · filed 2026-08-13 |
| 2026-04-30 | 294.61M shares 10-Q · filed 2026-05-14 |
| 2026-02-26 | 282.59M shares 10-K · filed 2026-03-05 |
| 2025-10-30 | 233.12M shares 10-Q · filed 2025-11-06 |
| 2025-08-01 | 120.14M shares 10-Q · filed 2025-08-14 |
| 2025-05-01 | 119.96M shares 10-Q · filed 2025-05-15 |
| 2025-03-11 | 119.96M shares 10-K · filed 2025-03-20 |
| 2024-11-01 | 119.62M shares 10-Q · filed 2024-11-14 |
| 2024-08-01 | 119.44M shares 10-Q · filed 2024-08-14 |
| 2024-05-02 | 119.32M shares 10-Q · filed 2024-05-09 |
| 2024-03-12 | 119.22M shares 10-K · filed 2024-03-28 |
| 2023-11-02 | 110.11M shares 10-Q · filed 2023-11-09 |
| 2023-08-03 | 109.76M shares 10-Q · filed 2023-08-10 |
| 2023-05-04 | 109.48M shares 10-Q · filed 2023-05-11 |
| 2023-03-16 | 109.19M shares 10-K · filed 2023-03-23 |
| 2022-11-03 | 108.98M shares 10-Q · filed 2022-11-10 |
| 2022-08-08 | 108.83M shares 10-Q · filed 2022-08-15 |
| 2022-05-06 | 109.72M shares 10-Q · filed 2022-05-13 |
| 2022-03-24 | 109.68M shares 10-K/A · filed 2022-04-29 |
| 2021-11-08 | 111.25M shares 10-Q · filed 2021-11-15 |
| 2021-09-13 | 111.25M shares 10-Q · filed 2021-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |